Etbx-021

Other Medications

EU Experimental ES Not available 1 Clinical Trials

Description

Etbx-021 is an investigational medication currently being studied by ImmunityBio, Inc. It is being evaluated in clinical trials, specifically in the context of colorectal cancer (CRC). The trials are in Phase 1, which means they are early-stage studies primarily focused on safety and determining the right dosage. Etbx-021 is being investigated in patients with metastatic CRC who have already received standard treatments. Some trials involving Etbx-021 include patients with specific genetic changes (mutations) in EGFR or VEGF genes. It is important to note that Etbx-021 is not yet approved for treating CRC or any other condition.

Mechanism of Action

The specific way Etbx-021 works (its mechanism of action) is still under investigation in clinical trials. It is being studied in combination with other therapies, including chemotherapy (like 5-Fluorouracil, Capecitabine) and targeted therapies (like Cetuximab, Regorafenib), as well as other investigational agents (like ALT-803, Avelumab, ETBX-011, ETBX-051, ETBX-061). The goal of these studies is to understand how Etbx-021 affects cancer cells and the body's response to cancer.

Side Effects

As Etbx-021 is an investigational drug in early-phase clinical trials (Phase 1) The full range of potential side effects is still being evaluated. Information about side effects is collected during these trials to assess the drug's safety. Specific side effect data for Etbx-021 in CRC patients is not yet widely available But as trials progress More information will become known. Patients participating in these trials are closely monitored for any adverse events.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT03563157 Phase 1
Archived
QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
United States

Quick Info

CategoryOther Medications
EU EMA StatusExperimental
ES Spain AccessNot available
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
771 trials
Leucovorin
Other Medications
631 trials
Trifluridine
Other Medications
45 trials
Paclitaxel
Other Medications
43 trials
Cyclophosphamid
Other Medications
40 trials
Cyclophosphamide
Other Medications
39 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.